Secondary primary malignancies
| . | n* . | Percentage . |
|---|---|---|
| Nonhematologic malignancies | 36 | (81.8) |
| Skin tumors | ||
| Melanoma | 2 | (4.5) |
| Basal cell carcinoma | 4 | (9.1) |
| Squamous cell carcinoma | 5 | (11.4) |
| Merkel cell carcinoma | 1 | (2.3) |
| Nonskin tumors | ||
| Gastrointestinal cancer | 8 | (18.2) |
| Pancreas cancer | 1 | (2.3) |
| Prostate cancer | 8 | (18.2) |
| Breast cancer | 1 | (2.3) |
| Lung cancer | 1 | (2.3) |
| Glioblastoma | 1 | (2.3) |
| Renal cell cancer | 2 | (4.5) |
| Adenocarcinoma with unknown primary | 1 | (2.3) |
| Soft tissue sarcoma | 1 | (2.3) |
| Hematologic malignancies | 8 | (18.2) |
| Acute myeloid leukemia | 1 | (2.3) |
| Diffuse large B-cell lymphoma | 1 | (2.3) |
| Follicular lymphoma | 2 | (4.5) |
| Marginal zone lymphoma | 1 | (2.3) |
| Lymphoplasmocytic lymphoma | 1 | (2.3) |
| T-cell lymphoma | 1 | (2.3) |
| Multiple myeloma | 1 | (2.3) |
| . | n* . | Percentage . |
|---|---|---|
| Nonhematologic malignancies | 36 | (81.8) |
| Skin tumors | ||
| Melanoma | 2 | (4.5) |
| Basal cell carcinoma | 4 | (9.1) |
| Squamous cell carcinoma | 5 | (11.4) |
| Merkel cell carcinoma | 1 | (2.3) |
| Nonskin tumors | ||
| Gastrointestinal cancer | 8 | (18.2) |
| Pancreas cancer | 1 | (2.3) |
| Prostate cancer | 8 | (18.2) |
| Breast cancer | 1 | (2.3) |
| Lung cancer | 1 | (2.3) |
| Glioblastoma | 1 | (2.3) |
| Renal cell cancer | 2 | (4.5) |
| Adenocarcinoma with unknown primary | 1 | (2.3) |
| Soft tissue sarcoma | 1 | (2.3) |
| Hematologic malignancies | 8 | (18.2) |
| Acute myeloid leukemia | 1 | (2.3) |
| Diffuse large B-cell lymphoma | 1 | (2.3) |
| Follicular lymphoma | 2 | (4.5) |
| Marginal zone lymphoma | 1 | (2.3) |
| Lymphoplasmocytic lymphoma | 1 | (2.3) |
| T-cell lymphoma | 1 | (2.3) |
| Multiple myeloma | 1 | (2.3) |
Number (%).